SII's CEO Adar Poonawalla took to Twitter to announce the "philanthropic" gesture.
The Centre on April 19 had announced a ''liberalised'' policy, making all above 18 years of age eligible to get vaccinated from May 1. It has also allowed state governments and private hospitals to purchase vaccines from manufacturers.
Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far
The Medicines and Healthcare Regulatory Agency, which had been formally tasked by the UK government last month with the process of clearance after the jab emerged "safe and effective" against the novel coronavirus in human trials, is expected to authorise the vaccine by December 28 or 29 after the final data is provided on Monday, 'The Daily Telegraph' quoted senior government sources as indicating.
PHE estimates that the vaccination programme in England has prevented 22 million infections, around 52,600 hospitalisations and between 35,200 and 60,000 deaths.
Serum Institute of India CEO Aadar Poonawalla has said that the production of Covid-19 vaccine Covishield is in full swing in Pune and he will review the operations once he is back in the country in a few days. Poonawalla is currently in the UK to meet his family members.
The further distribution of vaccine to the districts will be done as per the registered beneficiaries, for which a separate communication will be done shortly, the letter stated.
TCS was the top gainer in the Sensex pack, rising around 2 per cent, followed by ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank. The broader NSE Nifty surged hit a record high of 14,109.40.
India will be within its rights to initiate reciprocal measures if the UK does not address concerns over the new travel rules relating to COVID-19 vaccine certification, foreign secretary Harsh Vardhan Shringla said on Tuesday describing the policy as "discriminatory".
The comments by a spokesperson in the British High Commission in New Delhi came amid concerns in India over the latest Covid-related travel restrictions announced by the UK.
The US Food and Drug Administration had in February approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use.
The economics and pricing of the Covishield vaccines and the government's own decision to pay higher prices raise more than a few questions, observes Prosenjit Datta.
Several states and UTs including Delhi, Maharashtra, Karnataka and Telangana have decided to opt for global tenders for procurement of anti-coronavirus shots with the domestic supply falling short to meet the rising demand.
About 18-19 coronavirus vaccine candidates are in different clinical trial stages and may be available in the coming months, Health Minister Harsh Vardhan said on Monday.
"The initial supply price of Covishield for all government immunization programme, including India, has been the lowest", SII said.
This will be an upfront payment for the vaccine doses that these two companies will supply to the government.
'Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine for both doses,' Nordstrom said.
Putting an end to the vaccine certification row, the UK on Thursday announced that Indians, fully vaccinated with Covishield vaccine, will no longer require to undergo quarantine on their arrival in Britain from October 11.
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.
In a rare reference to private health matters, the 94-year-old monarch backed the National Health Service led vaccination programme in the UK during a video call earlier this week with health officials coordinating the rollout across England, Wales, Scotland and Northern Ireland.
"In addition to spreading more quickly, it also now appears that there is some evidence that the new variant - the variant that was first identified in London and the south east (of England) -- may be associated with a higher degree of mortality," Johnson said on Friday in his address at a virtual briefing from 10 Downing Street.
According to the Indian Council of Medical Research, 19,01,48,024 samples have been tested up to January 21 with 8,00,242 samples being tested on Thursday.
The United Kingdom will move India from 'red' to 'amber' list on August 8, according to the information available on the UK government website.
In a joint statement posted on their respective twitter accounts, the companies said Serum Institute Chief Executive Officer Adar Poonawalla and Bharat Biotech Chairman Krishna Ella communicated their combined intent to develop, manufacture and supply the COVID-19 vaccines.
The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
As per RDIF, Sputnik V has a number of key advantages, including that there are no strong allergies caused by Sputnik V.
PM Modi said that it was an honour to be a trusted partner during the pandemic adding that the two countries will continue to strengthen cooperation on healthcare.
David Quarrey, 55, a 10 Downing Street aide, had tested negative in his pre-travel test but tested positive a week after his return when the National Health Service flagged that someone on his flight had been traced as COVID-positive, The Sunday Times reports.
'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.
The Delta variant of COVID-19, or the B1.617.2 variant of concern (VOC) first identified in India, is about 60 per cent more transmissible than the Alpha strain identified in the United Kingdom and also reduces the effectiveness of vaccines to some extent, UK health experts report.
The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus.
The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.
The Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK before Thursday, speeding up the provision of the jab to the most vulnerable groups.
An important focus of the dry run will be on management of any possible adverse events following immunisation.
So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.
The Department of Health and Social Care said a total of 81,959,398 doses of COVID vaccines have been administered in the UK, with 46,227,101 people receiving a first dose (87.8 per cent) and 35,732,297 people receiving both doses (67.8 per cent).
By January-February, it's expected to have at least 100 million doses for the Indian government, reports Sohini Das.
The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.
Adar Poonawalla says it took a five-minute chat with his father Cyrus before making the decision to manufacture Covishield. The bet paid off, and handsomely. Serum Institute now has the capacity to make 4 billion doses of Covishield annually.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances